|
|
|
|
|
|
|
|
|
|
Ranbaxy Laboratories Ltd.- (Amalgamation)
|
|
|
|
|
|
|
|
|
BSE Code |
500359
|
|
ISIN Demat |
INE015A01028
|
|
Book Value (Rs) |
1.53
|
|
|
NSE Code |
NA
|
|
Dividend Yield % |
0.00
|
|
Market Cap(Rs Mn) |
366028.04
|
|
|
TTM PE(x) |
0.00
|
|
TTM EPS(Rs) |
-3.19
|
|
Face Value (Rs) |
5
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : MNC |
|
Incorporation Year
|
16-06 1961
|
|
Registered Office
|
A-41, Industrial Area Phase V I I I - A,Sahibzada Ajit Singh Nagar, , Mohali,
Punjab-160071 .
|
|
ISINNO
|
INE015A01028
|
|
Phone
|
91-172 6678666
|
|
E-mail
|
secretarial@ranbaxy.com |
|
URL
|
www.ranbaxy.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Tsutomu Une
|
|
Managing Director
|
Arun Sawhney
|
|
Company Secretary
|
Sushil K Patawari
|
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|